Home Healthcare Market (2023-2030)

The Home Healthcare Market is projected to reach $514.5 billion by 2030, at a CAGR of 7.9% from 2023 to 2030.

Published
Feb 2023
Pages
350
Format
PDF + Excel
Report ID
MRHC - 104148
Base year
2022
Market size · USD billion · 2022–2030Forecast 2023–2030 · 7.9% CAGR
2030 · FORECAST
$514.5B
2030
$514.5B
CAGR 2023–2030
7.9%
$600B$450B$300B$150B0
2022
2023
'24
'25
'26
'27
'28
'29
'30

2022 baseline · 2023–2030 forecast at 7.9% CAGR · hover a bar for the value

Key highlights

01

Based on offering, in 2023, the home therapeutic equipment segment is expected to account for the largest share of the home healthcare market

02

The growing need for equipment such as oxygen delivery equipment, ventilators, and home dialysis used in homecare settings for treating and managing chronic diseases such as kidney diseases and respiratory disorders is expected to contribute to the market growth of this segment.

03

Based on services, in 2023, the skilled care/nursing segment is projected to register the highest CAGR of the home healthcare market during the forecast period

04

The growth of this segment is attributed to the increasing need for home healthcare services, the rising geriatric population, the growing need for home-based treatment to prevent hospital-acquired infections, and the shift towards remote management of chronic diseases.

Report summary

ParticularsDetails
Base Year2022
Estimated Year2023
Forecast Period2023–2030
Market Size (2030)USD 514.50 billion
CAGR (2023–2030)7.9%
FormatPDF, Excel & Cloud Portal · 350 pages
Segments CoveredBy Offering: Home Tests and Patient Monitoring Equipment Fertility Tests & Aids, Pregnancy Tests, Gender, DNA, and Parental Tests, Cholesterol Tests, HIV Tests, Holter Monitors, Blood Pressure Monitors, Oximeters, Heart Rate Monitors, Thermometers, Stethoscopes, Defibrillators, Pedometers, Scales & Body Fat Monitors · By Service: Rehabilitation Services, Infusion Services, Skilled Care/Nursing, Unskilled Care Services, Telehealth Services, Hospice Care Services, Respiratory Therapy Services, Other Services · By Application: Cardiovascular Diseases & Hypertension, Diabetes, Respiratory Diseases, Pregnancy, Mobility Disorders, Cancer, Wound Care, Other Applications
Countries CoveredEurope (RoE)
Key CompaniesAmedisys, Inc, B. Braun SE, Baxter International, Inc., Halyard Health, Inc., F. Hoffmann-La Roche AG

Report overview

Scope note

Segments covered: offering, service, application. Regions: Europe.

Patients or individuals use home healthcare equipment and services to manage various conditions such as cardiovascular diseases, hypertension, diabetes, respiratory diseases, pregnancy, mobility disorders, cancer, wound care, and other conditions at home. Home healthcare is mostly used when a patient or individual requires prolonged care.

The increasing geriatric population, the growing adoption of home healthcare services due to the high cost of hospital healthcare services, and the rising prevalence of chronic diseases are driving the growth of the home healthcare market. Furthermore, the launch of technologically advanced products used in home healthcare settings, the growing preference for home care due to the high prevalence of infectious diseases, and the high market growth potential offered by developing economies are expected to offer significant opportunities for the market’s growth.

However, lack of reimbursement for home healthcare services and altered healthcare standards compared to hospital care are expected to restrain the growth of this market.

Report infographic

Home Healthcare Market
Home Healthcare Market · Report infographic

Home Healthcare as a Cost-effective Alternative to Hospital Healthcare Services

The emergence of home healthcare has enabled patients to receive hospital-like care in their homes and has also proved to be a cheaper, safer, and more effective alternative to traditional hospital care, mainly for those patients who are at risk of suffering from complications of inpatient care and hospital-acquired infections. These advantages of home care have led many countries, such as the U.S., U.K., Canada, Australia, and Israel, to implement government policies that encourage homecare health services. For instance, every regional and metropolitan hospital in Victoria, Australia, has a hospital-at-home program, and nearly 6% of all hospital bed-days are provided that way. (Source: The Commonwealth Fund). Furthermore, home care is widely adopted for specific conditions such as deep venous thrombosis (DVT) and acute cellulitis.

As per the Johns Hopkins Model, the cost of at-home care was 32% less than hospital care ($5,081 VS. $7,480), and the length of stay of the patients was also reduced by nearly one-third (3.2 days VS. 4.9 days). Additionally, the home care setting was found to be more convenient for family members and patients than those offered usual hospital care.

Nearly 5.6 million children in the U.S. receive nearly 5.1 hours of medical care at home, which saves approximately $36 billion annually (Source: Everyday Health, Inc. [U.S.]). These factors have led to the increased adoption of home healthcare as a cost-effective alternative to hospital healthcare services.

Additionally, the reduced need for rehospitalization and expensive and unnecessary testing and shorter treatment times are among the major factors propelling the adoption of home-based health services in developed and developing countries.

Market dynamics

2 factors across 1 force
01

According to the International Diabetes Federation (IDF),

the number of people with diabetes is expected to increase from 537 million in 2021 to 643 million in 2030 and 783 million in 2045

02

According to GLOBOCAN,

in 2020, 19.3 million people were diagnosed with cancer globally, which is expected to reach 24.6 million by 2030.

Table of contents

11 chapters · 133 sections · 350 pages · click to expand
Review the full research scope before you buy. Chapters can also be purchased individually.

1.1Market Definition
1.2Market Ecosystem
1.3Currency
1.4Key Stakeholders

Segmental analysis

SegmentLargest share (2023)Fastest growth (2023–2030)
By ApplicationDiabetes—
01

By Application

  • The diabetes segment is expected to account for the largest share of the home healthcare market
  • The growth of this segment is attributed to the rising cases of diabetes globally and the high prevalence of cardiovascular diseases and hypertension in diabetic patients.
CoversCardiovascular Diseases & HypertensionDiabetesRespiratory DiseasesPregnancyMobility DisordersCancerWound CareOther Applications

Geographic analysis

01

Asia-Pacific

Fastest growth

The growth of this regional market is attributed to the increasing geriatric population, the rising prevalence of chronic diseases in developing nations, the increasing investments in home healthcare in developing countries such as China and India, and the higher preference for home-based treatments due to the high costs of hospital services. Furthermore, government initiatives promoting homecare and the launch of advanced homecare products are driving the growth of the home healthcare market in Asia-Pacific. Asia-Pacific: Fastest-growing regional market

Competitive landscape

Companies profiled (5)
  • Amedisys, Inc
  • B. Braun SE
  • Baxter International, Inc.
  • Halyard Health, Inc.
  • F. Hoffmann-La Roche AG

Frequently asked questions

This study offers a detailed assessment of the home healthcare market and analyzes the market sizes & forecasts based on offering, services, and application. This report also involves the value analysis of various segments and subsegments of the home healthcare market at the regional and country levels.

Cite this report

Meticulous Research. (2023). Home Healthcare Market - Global Opportunity Analysis And Industry Forecast (2023-2030) (Report No. MRHC - 104148). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/home-healthcare-market-1280

Search Market Intelligence

Search across reports, blogs, press releases, and industries